Get started

ANGLE

Alternate names: ANGLE Europe Limited, ANGLE Europe Ltd, ANGLE plc
Country: GB
ROR: 04rj9em31
Crossref ID: 100017191
DOI: 10.13039/100017191
OpenAlex ID: F4320317193
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
2021 · Christian Rolfo, Philip Mack, et al. · Journal of Thoracic Oncology · 677
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
2020 · Elaine Kilgour, Dominic G. Rothwell, et al. · Cancer Cell · 360
PDF
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System
2015 · Lei Xu, Xueying Mao, et al. · PLoS ONE · 224
PDF
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
2020 · John T. Poirier, Julie George, et al. · Journal of Thoracic Oncology · 174
PDF
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer
2015 · Jakub Chudziak, Deborah J. Burt, et al. · The Analyst · 100
Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC
2019 · Sumitra Mohan, Victoria Foy, et al. · Journal of Thoracic Oncology · 81
PDF
Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
2020 · Carlos Alberto Aya-Bonilla, Michael Morici, et al. · British Journal of Cancer · 60
PDF
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
2021 · Desiree Loreth, Moritz Schuette, et al. · International Journal of Molecular Sciences · 56
PDF
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System
2022 · Evan N. Cohen, Gitanjali Jayachandran, et al. · Cancers · 55
PDF
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
2021 · Aliki Ntzifa, Areti Strati, et al. · Scientific Reports · 55
PDF
Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer
2019 · Eva Obermayr, Christiane Agreiter, et al. · Cells · 44
PDF
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells
2017 · Eva Obermayr, Elisabeth Maritschnegg, et al. · Oncotarget · 43
Role of trypsin and protease-activated receptor-2 in ovarian cancer
2020 · Kyu Kwang Kim, Rachael Turner, et al. · PLoS ONE · 40
PDF
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells
2019 · Lei Xu, Xueying Mao, et al. · The Journal of Urology · 40
PDF
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
2022 · Roisin E. O'Cearbhaill, Jose-Alejandro Pérez-Fidalgo, et al. · Gynecologic Oncology · 37
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
2022 · Alexander Ring, Daniel Campo, et al. · Annals of Surgical Oncology · 36
PDF
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
2017 · Sumitra Mohan, Francesca Chemi, et al. · Translational Lung Cancer Research · 36
PDF
Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
2021 · Aliki Ntzifa, Athanasios Kotsakis, et al. · Cancers · 32
PDF
Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
2023 · Karl Payne, Jill Brooks, et al. · British Journal of Cancer · 22
PDF
A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients
2021 · Sreeraj G. Pillai, Chidananda M. Siddappa, et al. · PLoS ONE · 22
PDF
Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection
2021 · Andi K. Cani, Emily M. Dolce, et al. · Molecular Oncology · 21
PDF
Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization
2020 · Evan N. Cohen, Gitanjali Jayachandran, et al. · PLoS ONE · 21
PDF
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
2023 · Caitlin R. Davies, Tianyu Guo, et al. · Frontiers in Oncology · 19
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
2021 · R.J. Lee, O. Wysocki, et al. · ESMO Open · 18
PDF
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
2024 · Volga M Saini, Ezgi Oner, et al. · Molecular Oncology · 16
Works count: 42
Citation count: 2,405
H-index: 21
I10-index: 32
2-year mean citedness: 6.5
Awards count: 1
Year
Topic
Type